Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Healthcare Sector Analysis

UpdatedAug 25, 2025
DataAggregated Company Financials
Companies86
  • 7D2.1%
  • 3M8.0%
  • 1Y-6.4%
  • YTD10.3%

In the last week, the Healthcare industry is up 3.2%, with AstraZeneca up 3.2%. In contrast, the industry has lost 6.4% in the last 12 months. Looking forward, earnings are forecast to grow by 13% annually.

Sector Valuation and Performance

Has the U.K. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 25 Aug 2025UK£314.4bUK£100.7bUK£12.0b29.3x26.2x3.1x
Wed, 23 Jul 2025UK£281.0bUK£99.4bUK£10.9b31.2x25.9x2.8x
Fri, 20 Jun 2025UK£286.4bUK£97.1bUK£10.8b28.8x26.6x2.9x
Sun, 18 May 2025UK£283.4bUK£97.9bUK£10.9b29.9x26.1x2.9x
Tue, 15 Apr 2025UK£276.1bUK£97.5bUK£9.7b29.1x28.5x2.8x
Thu, 13 Mar 2025UK£306.9bUK£98.3bUK£9.6b26.2x32x3.1x
Sat, 08 Feb 2025UK£303.5bUK£100.3bUK£9.4b28.4x32.2x3x
Mon, 06 Jan 2025UK£248.2bUK£86.5bUK£7.7b31.3x32.2x2.9x
Wed, 04 Dec 2024UK£253.4bUK£85.5bUK£7.6b29x33.4x3x
Fri, 01 Nov 2024UK£262.3bUK£83.1bUK£7.4b26.6x35.2x3.2x
Sun, 29 Sep 2024UK£275.6bUK£81.4bUK£8.8b30.4x31.4x3.4x
Tue, 27 Aug 2024UK£300.1bUK£81.9bUK£8.9b34.4x33.9x3.7x
Thu, 25 Jul 2024UK£282.5bUK£81.0bUK£9.3b32.7x30.3x3.5x
Sat, 22 Jun 2024UK£288.7bUK£82.0bUK£9.4b30.5x30.6x3.5x
Mon, 20 May 2024UK£291.4bUK£81.7bUK£9.4b33.7x31x3.6x
Wed, 17 Apr 2024UK£270.3bUK£81.8bUK£9.7b29.9x27.9x3.3x
Fri, 15 Mar 2024UK£263.6bUK£80.5bUK£9.6b34.5x27.6x3.3x
Sun, 11 Feb 2024UK£250.1bUK£79.7bUK£9.4b37.5x26.5x3.1x
Tue, 09 Jan 2024UK£276.8bUK£83.8bUK£10.6b40.4x26x3.3x
Thu, 07 Dec 2023UK£260.9bUK£84.4bUK£10.7b39.7x24.4x3.1x
Sat, 04 Nov 2023UK£263.3bUK£85.6bUK£10.9b41.2x24.1x3.1x
Mon, 02 Oct 2023UK£281.2bUK£85.9bUK£10.3b41.2x27.2x3.3x
Wed, 30 Aug 2023UK£274.1bUK£84.3bUK£10.2b41.3x26.9x3.3x
Fri, 28 Jul 2023UK£272.5bUK£82.3bUK£8.8b46.3x31.1x3.3x
Sun, 25 Jun 2023UK£283.9bUK£82.6bUK£7.9b45.4x36x3.4x
Tue, 23 May 2023UK£294.1bUK£83.6bUK£8.0b47.7x36.8x3.5x
Thu, 20 Apr 2023UK£295.8bUK£84.2bUK£6.9b47x42.8x3.5x
Sat, 18 Mar 2023UK£271.5bUK£85.2bUK£6.9b40.1x39.2x3.2x
Mon, 13 Feb 2023UK£286.4bUK£85.4bUK£7.6b37.1x37.5x3.4x
Wed, 11 Jan 2023UK£291.5bUK£94.9bUK£6.6b36.5x44.2x3.1x
Fri, 09 Dec 2022UK£284.7bUK£94.7bUK£6.6b36.8x43.2x3x
Sun, 06 Nov 2022UK£272.0bUK£96.2bUK£4.0b29x67.9x2.8x
Tue, 04 Oct 2022UK£251.7bUK£96.1bUK£4.0b27.5x62.8x2.6x
Thu, 01 Sep 2022UK£269.5bUK£94.5bUK£4.1b36.1x65.9x2.9x
Price to Earnings Ratio

65.9x


Total Market Cap: UK£269.5bTotal Earnings: UK£4.1bTotal Revenue: UK£94.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthcare Sector Price to Earnings3Y Average 36.2x202320242025
Current Industry PE
  • Investors are pessimistic on the British Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 26.2x which is lower than its 3-year average PE of 36.3x.
  • The industry is trading close to its 3-year average PS ratio of 3.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 43% per year over the last three years.
  • Revenues for these companies have grown 2.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare sector?

GB Market0.73%
Healthcare2.08%
Biotech3.38%
Medical Equipment3.21%
Pharma2.02%
Healthcare Services1.76%
Healthtech0.56%
Life Sciences-0.91%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 23.1%, which is lower than the prior year's growth of 58.9% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 34% over the next 5 years.
  • This is better than its past earnings decline of 34% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£119.682.0%
+UK£3.6b		-8.5%PE30.2x
GSK GSKUK£14.802.8%
+UK£1.6b		-7.7%PE17.4x
HLN HaleonUK£3.651.1%
+UK£349.3m		-1.8%PE21.5x
SN. Smith & NephewUK£13.832.6%
+UK£297.3m		18.1%PE33.2x
CTEC ConvaTec GroupUK£2.435.3%
+UK£249.4m		3.1%PE31x

Latest News

ONT
UK£2.08
Oxford Nanopore Technologies
7D
-0.8%
1Y
70.9%

We Think Oxford Nanopore Technologies (LON:ONT) Can Afford To Drive Business Growth

Aug 21
We Think Oxford Nanopore Technologies (LON:ONT) Can Afford To Drive Business Growth
AZN
UK£119.68
AstraZeneca
7D
2.0%
1Y
-8.5%
SCLP
UK£0.10
Scancell Holdings
7D
-2.4%
1Y
-38.8%
OXB
UK£5.42
Oxford Biomedica
7D
8.4%
1Y
54.9%
SVNS
UK£0.0031
Solvonis Therapeutics
7D
-10.3%
1Y
52.5%
GSK
UK£14.80
GSK
7D
2.8%
1Y
-7.7%
CTEC
UK£2.43
ConvaTec Group
7D
5.3%
1Y
3.1%
HIK
UK£18.36
Hikma Pharmaceuticals
7D
1.9%
1Y
-8.8%
SN.
UK£13.83
Smith & Nephew
7D
2.6%
1Y
18.1%

Orthopaedic Solutions And Wound Management Will Expand Global Reach

Smith & Nephew's consensus analyst price target has risen to £13.30, reflecting a lower expected future P/E and slightly stronger revenue growth forecasts. What's in the News Smith+Nephew launched the Q-FIX KNOTLESS All-Suture Anchor, featuring market-leading fixation strength, proprietary suture lock mechanism, and streamlined suture shuttling for various joint repairs.
EKF
UK£0.27
EKF Diagnostics Holdings
7D
-2.5%
1Y
-4.1%
HLN
UK£3.65
Haleon
7D
1.1%
1Y
-1.8%
SPEC
UK£0.44
INSPECS Group
7D
-7.4%
1Y
-16.2%
AVCT
UK£0.49
Avacta Group
7D
-3.4%
1Y
-35.1%
FAB
UK£0.13
Fusion Antibodies
7D
-17.2%
1Y
295.5%
GNS
UK£26.85
Genus
7D
2.9%
1Y
54.8%

There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Jul 25
There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise
ANCR
UK£2.60
Animalcare Group
7D
-1.9%
1Y
-4.8%